Henry Schein (HSIC) has had a dynamic time in the market, facing both peaks and valleys. With the veteran CEO
Stanley Bergman announcing his retirement, the impact on the company's digital transformation and efficiency goals has become a point of discussion. The company has raised concerns due to a
decrease in its market share, leading to a downgrade in the stock at Stifel, with a price target cut — But despite market challenges, the stock remains a top-ranked value and a
momentum stock for the long-term. As part of strategic shifts to navigate a flat revenue,
Henry Schein secured a substantial $250 Million investment from KKR, leading to a slight surge in shares and it also
completed the acquisition of Acentus, a leading supplier of homecare medical products. Q1 2025 had the earnings fall below analyst estimates, with sales displaying a declining trend. There was a discrepancy in expected and actual earnings in Q4 2024 that surprised stakeholders, however, the financial guidance for 2025 has detailed a promising forecast. The company continues its dedication to ethical business, being recognized by Ethisphere for the 14th consecutive year.
Henry Schein HSIC News Analytics from Wed, 25 Sep 2024 07:00:00 GMT to Fri, 25 Jul 2025 19:41:51 GMT -
Rating -2
- Innovation 3
- Information 5
- Rumor -4
